OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.050
+0.090 (4.59%)
At close: Aug 13, 2025, 4:00 PM
2.100
+0.050 (2.44%)
Pre-market: Aug 14, 2025, 9:02 AM EDT
OmniAb Employees
OmniAb had 114 employees as of December 31, 2024. The number of employees increased by 8 or 7.55% compared to the previous year.
Employees
114
Change (1Y)
8
Growth (1Y)
7.55%
Revenue / Employee
$201,991
Profits / Employee
-$557,158
Market Cap
251.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 114 | 8 | 7.55% |
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Dec 31, 2020 | 70 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OABI News
- 7 days ago - OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights - Business Wire
- 4 weeks ago - OmniAb to Report Second Quarter 2025 Financial Results on August 6 - Business Wire
- 3 months ago - OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit - Business Wire
- 3 months ago - OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - OmniAb Reports First Quarter 2025 Financial Results and Business Highlights - Business Wire
- 3 months ago - OmniAb Introduces the xPloration® Partner Access Program - Business Wire
- 3 months ago - VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program - GlobeNewsWire